机译:曲妥珠单抗联合化学疗法一线治疗且不超过HER2高表达晚期乳腺癌进展的疗效和安全性
Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China;
Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China;
Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China;
Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China;
Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China;
Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China;
Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China;